Composition comprising radioactive labeled-fibrinogen and albumin
US3933996A · kind A · utility
13Cited by
4References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 19, 1973 |
| Grant date | Jan 20, 1976 |
| Priority date | — |
| Expiry date | Jun 19, 1993 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2121/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The stability of fibrinogen is improved by mixing it with albumin, preferably at least 5 parts by weight of albumin per part by weight of fibrinogen. By this invention, iodinated (.sup.125 I) human fibrinogen can be stabilised with human serum albumin for use in the diagnosis of thrombi.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.